Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.
about
Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.Survival and hepatitis status among Asian Americans with hepatocellular carcinoma treated without liver transplantationHepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study.Hepatitis B testing and vaccination in immigrants attending English as a second language classes in British Columbia, Canada.Symptom management in hepatocellular carcinomaFactors associated with hepatitis B testing among Vietnamese Americans.Disparities in liver cancer incidence by nativity, acculturation, and socioeconomic status in California Hispanics and Asians.Hepatitis B and alcohol affect survival of hepatocellular carcinoma patients.Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-AmericansTheoretically informed correlates of hepatitis B knowledge among four Asian groups: the health behavior framework.National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003.The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004.Relationship between humoral response against hepatitis C virus and disease overcome.Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass.Tumor factors associated with clinical outcomes in patients with hepatitis B virus infection and hepatocellular carcinoma.Factors associated with ethnical disparity in overall survival for patients with hepatocellular carcinoma.
P2860
Q27472734-0B10677C-B903-4599-913A-9FCEF480199AQ33405646-ED25FAD1-EF8C-4FF7-952B-ECD81939D6B6Q33534469-FBB96CB0-4E05-4271-9C20-A2BBD93A2FA8Q33821988-33E4AFE5-6B7C-4064-A928-FB6E59118045Q33897458-D20B10E7-4654-45A4-BD88-56AA8CD2B38FQ33898767-C321A11A-9163-4496-8A7A-5AC109F370BBQ34422414-02360F56-A9A5-4BDF-81ED-1E35B3A836F2Q35045196-73A4EFDD-48D1-4DC6-ABE7-FC4FC2CF8CF1Q35163337-7A54D0D5-44D2-471E-A84F-0CFA9CE769B2Q36182384-A93B1FAB-DC43-4EF7-9B20-1DA47AE410FFQ36790704-EF41D2F4-7003-4971-BA71-DF99B5E8C943Q37421369-3C8DA3FF-1C76-480F-9F16-6464974F142BQ37558730-AA6ED27A-EB93-45E4-B9C2-6DFBFA576044Q37669086-5ABD8362-98EF-4114-AAF1-F67DDA427688Q37677885-7F21CBB1-9DAA-4DB9-87D6-77927CD1B4B4Q37716521-F05D6532-5038-4176-B8FE-6204CD6B2E1F
P2860
Evaluation of hepatitis B and C viral markers: clinical significance in Asian and Caucasian patients with hepatocellular carcinoma in the United States of America.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Evaluation of hepatitis B and ...... the United States of America.
@en
Evaluation of hepatitis B and ...... the United States of America.
@nl
type
label
Evaluation of hepatitis B and ...... the United States of America.
@en
Evaluation of hepatitis B and ...... the United States of America.
@nl
prefLabel
Evaluation of hepatitis B and ...... the United States of America.
@en
Evaluation of hepatitis B and ...... the United States of America.
@nl
P2093
P1476
Evaluation of hepatitis B and ...... n the United States of America
@en
P2093
P304
P577
1996-10-01T00:00:00Z